Return to Listing

263 result(s) for Hematologic Cancers

PI Name Protocol # Title
Edward Neuwelt IRB00000922 Phase II Clinical Trial of Patients with High-Grade Glioma Treated with Intra-arterial Carboplatin-based Chemotherapy, Randomized to Treatment with or without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant against Severe Thrombocytopenia
Edward Neuwelt IRB00001012 A Phase II Study of Patients with Newly Diagnosed Primary Central Nervous System Lymphoma Treated with Methotrexate/BBBD, and Adding Rituximab (an anti CD-20 Antibody) and Carboplatin, to the Treatment Regimen
Grazyna Adamus IRB00002421 Mechanism of Retinal Damage in Autoimmune Retinopathy
Bonnie Nagel IRB00002560 Neurocognition and Brain Development in Youth (Attention Deficit)
Edward Neuwelt IRB00002868 Phase I/II Study of Carboplatin, Melphalan and Etoposide Phosphate in Conjunction with Osmotic Opening of the Blood-Brain Barrier and Delayed Intravenous Sodium Thiosulfate Chemoprotection, in Previously Treated Subjects with Anaplastic Oligodendroglioma or Oligoastrocytoma
Vassiliki Tsikitis IRB00003082 Oregon Colorectal Cancer Registry
William Rooney IRB00003290 MRI Protocol Development and Optimization
Brett Sheppard IRB00003609 Oregon Pancreas Tissue Registry
Fay Horak IRB00004131 Exercise, Brain Imaging, Cognition, and Gait in Parkinsonism
Cary Harding IRB00004206 Longitudinal Study of Urea Cycle Disorders
Wei Huang IRB00004840 Quantitative Dynamic Contrast-Enhanced Breast MRI
Andrew Ahmann IRB00005023 TrialNet Natural History Study of the Development of Type 1 Diabetes
Fay Horak IRB00005029 Development of the Instrumented Test of Mobility (iMOBILITY)
Edward Neuwelt IRB00005056 Phase I/II Study of Intra-arterial Melphalan Given with Intra-arterial Carboplatin, Osmotic Blood-Brain Barrier Disruption and Delayed Otoprotective Sodium Thiosulfate for Patients with Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Kevin Billingsley IRB00005222 Oregon Liver Tumor Registry
Jeff Kraakevik IRB00005508 National Parkinson Foundation Patient Registry
Lina Reiss IRB00006069 VAPORHCS/OHSU J:Optimization of Cochlear Implants and Hearing Aids
Kathleen Kemmer IRB00006256 I-SPY 2 TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2
Penelope Hogarth IRB00006459 The Parkinson's Progression Markers Initiative (PPMI)
Joel Nigg IRB00006749 Developmental Origins of Attention Deficit Hyperactivity Disorder
Stephen Spurgeon IRB00007195 A Phase II Proof of Concept Trial to Study Kinase Inhibition in Relapsed/Refractory Acute Leukemias: Using a Comprehensive in Vitro Kinase Inhibitor Panel to Select Individualized Targeted Therapies
Andrew Ahmann IRB00007319 Harold Schnitzer Diabetes Health Center Research Department Contact and Health Information Repository
Christopher Ryan IRB00007943 A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination with Pazopanib for Refractory Soft Tissue Sarcoma
James Rosenbaum IRB00008052 Objective grading of intraocular inflammation in uveitis using optical coherence tomography
Amit Punj IRB00008112 Clinical investigation of the new nanohybrid resin composite Venus Pearl in class 2 cavities- a multi-center study.
James Rosenbaum IRB00008466 Relationship between HLA B27, disease status and the human microbiome
Akram Khan IRB00008597 A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Event Driven Study to Compare the Time to First Clinical Worsening in Subjects with Pulmonary Arterial Hypertension Receiving UT-15C in Combination with a PDE5-I or ERA Compared with a PDE5-I or ERA Alone
Kristen Mackiewicz Seghete IRB00009182 Neural Mechanisms of Cognitive Inhibition in Youth with and without a Trauma History
Tomasz Beer IRB00009204 Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms of Resistance
Joshi Alumkal IRB00009259 Identifying Mechanisms of Resistance to Enzalutamide (MDV3100) Treatment in Men with Castration-Resistant Prostate Cancer
Richard Maziarz IRB00009375 A Phase 1-2 Dose Escalation Study Evaluating Safety and Feasibility of BPX-501 T Cells after Partially Mismatched, Related, T Cell-Depleted HSCT
Rodney Pommier IRB00009420 Oregon Index of Endocrine Neoplasias (ORION)
Alfons Krol IRB00009517 A Multicenter, Open-label, Phase 1 Study of the Safety, Tolerability, Systemic Exposure, Pharmacodynamics, and Treatment Effect of Calcipotriene Foam, 0.005%, in Pediatric Subjects (Ages 2 to 11 Years) with Plaque Psoriasis
John Morrison IRB00009729 Longitudinal observational study using functional and structural optical coherence tomography to diagnose and guide treatment of glaucoma
Matthew Taylor IRB00009902 A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
Steven Shea IRB00010101 Circadian rhythms and cardiovascular risk
Kevin Winthrop IRB00010178 The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF Users
William Messer IRB00010212 VAPORHCS/OHSU J: Identifying the Determinants of Long-Term Type Specific Immunity in a Dengue Immune Cohort
Kim-Hien Dao IRB00010262 Prospective Evaluation of ruxolitinib Efficacy for CNL/aCML Patients with Mutation of CSF3R
Mark Garzotto IRB00010345 VAPORHCS/OHSU J Contrast Enhanced MRI of the Prostate
Stephen Spurgeon IRB00010383 A Phase 1 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-Lag-3 (BMS-986016) in Relapsed or Refractory Chronic Lymphocytic Leukemia and Lymphomas
Kevin Winthrop IRB00010433 A pilot study for the Varicella Zoster Vaccine (VERVE) Trial
Frederick Tibayan IRB00010527 A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass (GTI-1307)
Lara Davis IRB00010529 SARC024: A blanket protocol to study oral regorafenib in patients with selected sarcoma subtypes
Michael Heinrich IRB00010537 A Phase I, Multicenter, Open-Label Study of Oral ABL001 in Patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Sancy Leachman IRB00010561 War on Melanoma: Enlisting a cohort of melanoma survivors and their families
Peter Jacobs IRB00010708 Improving speech intelligibility in noise through an interactive video game
Anna Wilson IRB00010782 Maternal Chronic Pain
Julie Graff IRB00011025 Addition of Pembrolizumab Upon Progression on Enzalutamide in men with mCRPC
Khaled Tolba IRB00011046 [NCI CIRB]S1400: Lung-MAP, Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
Emma Scott IRB00011097 A Feasibility Study of Myeloablative BEAM Allogeneic Transplantation Followed by Oral Ixazomib Maintenance Therapy in Patients with Relapsed High-Risk Multiple Myeloma
Daniel Herzig IRB00011161 A Phase II Multicenter Randomized Trial Evaluating 3-Year Disease-Free Survival in Patients with Locally Advanced Rectal Cancer Treated with Chemoradiation Plus Induction or Consolidation Chemotherapy, and Total Mesorectal Excision or Non-Operative Management
Wayne Clark IRB00011170 VAPORHCS/OHSU J: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (VA/OHSU (J): CREST-2)
Nicole Marshall IRB00011175 Maternal Body Composition Regulates Placental Function and Fetal Growth
Julie Graff IRB00011227 VAPORHCS/OHSU J: A Phase I/II Trial of Concurrent Chemohormonal Therapy Using Enzalutamide (MDV-3100) and Cabazitaxel in Patients with Metastatic Castration Resistant Prostate Cancer
Gina Vaccaro IRB00011256 Phase 2 Study of Preoperative Chemotherapy with Abraxane and Gemcitabine Followed by Chemoradiation for Borderline Resectable or Node-Positive Pancreatic Cancer
Melanie Gillingham IRB00011258 Role of Fatty Acid Oxidation Defects in Insulin Sensitivity
Arthur Hung IRB00011268 Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide (MDV3100) in Men with High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy
Larisa Tereshchenko IRB00011299 Adaptive CRT effect on ELectrical dysSYNChrony (aCRT ELSYNC)
Kathleen Kemmer IRB00011351 A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
Sarah Feldstein Ewing IRB00011481 Motivational Interviewing and Neuroimaging with Adolescents (MINA)
Jeffrey Kaye IRB00011606 Alzheimer's Comprehensive Treatment Network of Oregon and Washington (ACTNOW!)
Matthew Taylor IRB00011688 A Phase 1 Study of the Oral TRK Inhibitor LOXO-101 in Adult Patients with Solid Tumors
Stephen Spurgeon IRB00011766 A Phase Ib Feasibility Study of Personalized Kinase Inhibitor Therapy Combined with Induction in Acute Leukemias who Exhibit in vitro Kinase Inhibitor sensitivity
Nir Modiano IRB00011801 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
Michelle Cameron IRB00011805 VAPORHCS/OHSU J: Comprehensive Fall Prevention and Detection in MS
Jeremy Cetnar IRB00011845 A Phase III, Open-Label, Multicenter, Randomized Study of Atezolizumab (Anti-PD-LI Antibody) Compared with A Platinum Agent (Cisplatin or Carboplatin) in Combination with either Pemetrexed or Gemcitabine for PD-L1-Selected, Chemotherapy-Naïve Patients Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
Barry Oken IRB00011847 Meditation or Health & Wellness Education via Internet for Adults 50-80 Years Old
Kathryn Chung IRB00011875 Buspirone, in combination with amantadine, for the treatment of levodopa-induced dyskinesia (VA MIRB 3753)
Brandon Hayes-Lattin IRB00011894 Protocol CCTL019B2206: A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial
Brandon Hayes-Lattin IRB00011960 Long Term Follow-Up of Patients Exposed to Lentiviral- Based CD19 directed CART Cell Therapy
Matthew Taylor IRB00012008 CPDR001X2101: Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001 Administered to Patients with Advanced Malignancies
Khaled Tolba IRB00012012 A Phase III, Open-Label, Randomized Study To Investigate The Efficacy And Safety Of Atezolizumab (ANTI−PD-L1 ANTIBODY) Compared With Best Supportive Care Following Adjuvant Cisplatin-Based Chemotherapy In Patients With Completely Resected STAGE IB−IIIA Non-Small Cell Lung Cancer
Stephen Heitner IRB00012026 [MOU-Vanderbilt-IRBShare] Exercise in Genetic Cardiovascular Conditions
Lara Davis IRB00012039 Sarcoma Survivorship Registry
Michael Heinrich IRB00012061 A Phase 1 Study of BLU-285 in Patients with Gastrointestinal Stromal Tumors (GIST) and other Relapsed and Refractory Solid Tumors
Ahmed Raslan STUDY00015004 AMES+tDCS brain stimulation
Laurie King STUDY00015010 VAPORHCS/OHSU J: Rehabilitation of Central Sensory Impairments for Balance in mTBI
Sarah Bartholomew STUDY00015025 Neurophysiological Attention Test (NAT) for Objective Assessment of ADHD
Larisa Tereshchenko STUDY00015049 Pilot observational case-control study of the electrical heterogeneity in patients with hypertrophic cardiomyopathy and high arrhythmic-risk
Michael Heinrich STUDY00015085 A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients with Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Damien Fair STUDY00015099 Early Neurobiological Predictors of Executive Functioning in Toddlers
Alexey Danilov STUDY00015136 A Phase 1B Dose Escalation and Dose Expansion Study of ONO/GS-4059 in Combination with Other Targeted Anti-cancer Therapies in Subjects with B-cell Malignancies
William Rooney STUDY00015146 Magnetic Resonance Imaging (MRI) and 18F-Florbetapir PET for Detecting Glio-vascular Changes that Slow Amyloid Beta Clearance from the Aging Brain.
Arpana Naik STUDY00015164 A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Antonio Frias STUDY00015196 Functional imaging of human placenta by MRI
Matthew Taylor STUDY00015206 An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
Rachel Cook STUDY00015214 A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies
Frederick Gallun STUDY00015217 VAPORHCS/OHSU J: Efficient diagnostic tools to evaluate central auditory dysfunction
Jeremy Cetnar STUDY00015218 A Phase 3 Prospective, Randomized, Double-Blind, Multi-Center, Study Of The Efficacy And Safety Of Lanreotide Autogel/ Depot 120mg Plus BSC Vs Placebo Plus BSC For Tumor Control In Subjects With Well-Differentiated, Metastatic And/Or Unresectable Typical Or Atypical Lung Neuroendocrine Tumors
Jan Van Santen STUDY00015226 Automatic Voice-Based Assessment of Language Abilities
Stephen Spurgeon STUDY00015255 IIT: A Phase II study of Obinutuzumab (GA-101) in Combination with Ibrutinib (I) for the Treatment of Relapsed Mantle Cell Lymphoma (ML29535)
Arthur Hung STUDY00015290 A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment with Primary Radiation Therapy
Kim-Hien Dao STUDY00015363 WEAR in Oregon: Defining risks of blood cancer development in a cohort of older women with clonal hematopoiesis and TET2 mutations. (Women Engaged in Advancing health Research in Oregon is a prospective epidemiology study)
Kathleen Kemmer STUDY00015366 ONT-380-206: Phase 2 Randomized, Double-Blinded, Controlled Study of tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
John Campbell STUDY00015419 Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk (Protocol W)
Kathryn Holmes STUDY00015426 Effectiveness of Fetal Counseling in Congenital Heart Disease
Amie Hiller STUDY00015494 (MOU NeuroNEXT NN105) An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects with Huntington's Disease (HD)
Eric Fombonne STUDY00015593 Oregon SPARK: National Autism Cohort 50k
Jeremy Cetnar STUDY00015597 A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versusPlacebo in Subjects with High Risk Invasive Urothelial Carcinoma
Marcel Curlin STUDY00015598 CMV seroprevalence and feasibility of CMV-vectored prophylactic immunization trial
Elie Traer STUDY00015601 A Phase 1, Multi-center, Open-label Study of IMGN779 Administered Intravenously in Adult Patients with Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Eva Medvedova STUDY00015608 Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Lara Davis STUDY00015649 A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Matthew Taylor STUDY00015678 A Phase 1a/1b Study of Cabiralizumab in Combination with Nivolumab in Patients with Selected Advanced Cancers
Kevin Winthrop STUDY00015682 Clofazimine in the treatment of pulmonary Mycobacterium avium complex (MAC) disease
Brett Sheppard STUDY00015705 The OHSU Pancreas Community Registry
Matthew Taylor STUDY00015752 A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination with Epacadostat in Adults with Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer
Chafic Karam STUDY00015773 Cross-Sectional ALS Biofluid Biomarker (CABB) Study
Vijayshree Yadav STUDY00015779 MitoQ for fatigue in multiple sclerosis: A placebo controlled trial
Lynne Morrison STUDY00015823 The Efficacy of Topical Silver Nitrate Versus Cryotherapy in the Treatment of Common Warts
Jennifer Barton STUDY00015851 VAPORHCS/OHSU J: Goal concordance in rheumatoid arthritis: a survey study
Emma Scott STUDY00015863 A Phase 1/2 Open label trial of SL-401 in combination with Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
Rachel Cook STUDY00015903 A Randomized, Phase II Study of CX-01 Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia
Matthew Taylor STUDY00015911 A Phase 1b Open-Label Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined with Pembrolizumab in Subjects with Selected Hyaluronan-High Solid Tumors
Kerri Winters STUDY00015921 INTense Exercise foR surVivAL among men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-MCRPC): A Multicenter, Randomized, Controlled, Phase III Study
Matthew Taylor STUDY00015941 A Phase 1b/2, Open-label, Dose Escalation Study of Entinostat in Combination with Pembrolizumab in Patients with Non-small Cell Lung Cancer, with Expansion Cohorts in Patients with Non-small Cell Lung Cancer, Melanoma, and Mismatch Repair-Proficient Colorectal Cancer.
Rachel Cook STUDY00015953 A Biomarker-Directed Phase 2 Trial of SY-1425, a Selective Retinoic Acid Receptor Alpha Agonist, in Adult Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Kim-Hien Dao STUDY00015977 [NCI CIRB] The National Myelodysplastic Syndromes (MDS) Study
Christopher Ryan STUDY00015989 A PHASE 2-3, MULTICENTER, RANDOMIZED, DOUBLE BLIND STUDY OF SELINEXOR (KPT-330) VERSUS PLACEBO IN PATIENTS WITH ADVANCED UNRESECTABLE DEDIFFERENTIATED LIPOSARCOMA (DDLS)
Rachel Cook STUDY00015993 A Phase I Dose Finding Study Evaluating Safety and Feasibility of BPX-701 in Patients with Relapsed or Refractory Myeloid Neoplasm
Matthew Taylor STUDY00016017 An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors
Mark Pennesi STUDY00016018 A Multiple-Site, Phase 1/2, Safety and Efficacy Trial of AGTC-402, a Recombinant Adeno-associated Virus Vector Expressing CNGA3, in Patients with Congenital Achromatopsia Caused by Mutations in the CNGA3 Gene
Skye Mayo STUDY00016033 A Phase II study of induction systemic mFOLFIRINOX followed by hepatic arterial infusion of Floxuridine and Dexamethasone given concurrently with systemic mFOLFIRI as a first-line therapy in patients with unresectable liver-dominant intrahepatic cholangiocarcinoma
Edward Neuwelt STUDY00016046 Response Assessment to Pembrolizumab with Standard of Care Therapy in Oligometastatic Brain Tumors from Melanoma, and Glioblastoma Using Ferumoxytol Steady State Imaging– A Pilot Study
Gina Vaccaro STUDY00016058 CA209-577: A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer (CheckMate 577: CHECKpoint pathway and nivoluMab clinical Trial Evaluation 577)
Lara Davis STUDY00016070 A Phase 1B Study of Ribociclib in Combination with Doxorubicin in Advanced Soft Tissue Sarcomas
Christopher Ryan STUDY00016085 [NCI CIRB] A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)
Gina Vaccaro STUDY00016107 ARRAY-818-302: A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5- Fluorouracil (5-FU)/Folinic Acid (FA) /Irinotecan (FOLFIRI)/Cetuximab with a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients with BRAF V600E-mutant Metastatic Colorectal Cancer
Alexey Danilov STUDY00016140 A Phase I/II study of Syk inhibitor entospletinib (GS-9973) in combination with obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and B-cell malignancies
Curtis Billings STUDY00016148 VAPORHCS/OHSU J: The brain-behavior relationship: age, hearing, and their effects on understanding speech in noise
Joshi Alumkal STUDY00016149 A Phase 1b/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination with Enzalutamide in Subjects with Metastatic Castrate-Resistant Prostate Cancer
Richard Maziarz STUDY00016189 A Phase 1 Non-Randomized, Open-Label/Phase 2 Randomized, Blinded Study of ProTmune (ex vivo Programmed Mobilized Peripheral Blood Cells) Versus Non-Programmed Mobilized Peripheral Blood Cells for Allogeneic Hematopoietic Cell Transplantation in Adult Subjects with Hematologic Malignancies
Cherrie Abraham STUDY00016197 Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta
Matthew Taylor STUDY00016198 A Phase 1 Dose Escalation Trial of Intratumoral Injections of TTI-621 in Subjects with Relapsed and Refractory Percutaneously-Accessible Solid Tumors and Mycosis Fungoides
Miriam Treggiari STUDY00016228 Randomized Trial of Early Hemodynamic Management of Patients following Acute Spinal Cord Injury (TEMPLE)
Khaled Tolba STUDY00016230 A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination with Ipilimumab versus Nivolumab in combination with Ipilimumab placebo Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Dennis Crawford STUDY00016254 A Phase 3 Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D, Compared to Microfracture in the Treatment of Articular Cartilage Defects
Gina Vaccaro STUDY00016255 INCB 54828-202: A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy
Lisa Silbert STUDY00016260 Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3)
William Rooney STUDY00016286 fMRI Neurofeedback of the Amygdala for Treatment of PTSD in Combat Veterans
Alison Edelman STUDY00016291 Improving the effectiveness of orally-dosed emergency contraceptives in obese women
Joshi Alumkal STUDY00016294 Phase 1 Safety and Tolerability Study of ZEN003694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ZEN003694-002)
Uma Borate STUDY00016338 A Phase 1/1b Open-Label Study to Determine the Safety and Tolerability of ALRN-6924 alone and in combination with cytarabine (Ara-C) in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome With Wild-Type TP53
Jeffrey Kaye STUDY00016347 A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer's Disease
Khaled Tolba STUDY00016349 [Quorum] CINC280A2201: A phase II, multicenter, four-cohort study of oral cMET inhibitor INC280 in adult patients with EGFR wild-type (wt), advanced non-small cell lung cancer (NSCLC) who have received one or two prior lines of systemic therapy for advanced/metastatic disease
Brandon Togioka STUDY00016351 An assessor-blinded, randomized, controlled, single center, parallel design trial to compare the incidence of postoperative pulmonary complications (PPCs) associated with rocuronium neuromuscular reversal with Sugammadex versus Neostigmine in patients 70 years of age or older undergoing surgery of at least 3 hours (SugPPC)
Kim-Hien Dao STUDY00016363 A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
Michael Heinrich STUDY00016365 CrenoGIST– A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene
Brandon Cornejo STUDY00016370 VAPORHCS/OHSU J: The use of repetitive transmagnetic stimulation to target craving in methamphetamine use disorder (MIRB 3856)
Arthur Hung STUDY00016373 A Pilot Study Investigating 18F-FLT-PET as a Marker of Response to Preoperative Radiotherapy in Soft Tissue Sarcoma
Kathleen Kemmer STUDY00016379 C31006: An Open-Label Phase 2 Study of MLN0128 (A TORC1/2 Inhibitor) in Combination With Fulvestrant in Women With ER-Positive/HER2-Negative Advanced or Metastatic Breast Cancer That Has Progressed During or After Aromatase Inhibitor Therapy
Jacqueline Vuky STUDY00016390 A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel plus Dexamethasone (SEVI-D) in Subjects with Advanced Breast Cancer
Rachel Cook STUDY00016429 A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the FLT3 Inhibitor Gilteritinib (ASP2215) Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects with FLT3/ITD AML in First Complete Remission
Julie Graff STUDY00016446 A Safety and Pharmacokinetics Study of Niraparib plus androgen receptor-targeted therapy (apalutamide or abiraterone acetate and prednisone) in Men with Metastatic Castration-Resistant Prostate Cancer (protocol 64091742PCR1001)
Uma Borate STUDY00016475 A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)
Jacqueline Vuky STUDY00016506 A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinoma
Bonnie Nagel STUDY00016521 Neurocircuitry of acute alcohol intoxication in individuals at familial history risk for alcoholism
Julie Graff STUDY00016539 A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration Resistant Prostate Cancer and DNA - Repair Anomalies (protocol 64091742PCR2001)
Christopher Ryan STUDY00016576 A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ATEZOLIZUMAB (ANTI−PD-L1 ANTIBODY) AS ADJUVANT THERAPY IN PATIENTS WITH RENAL CELL CARCINOMA AT HIGH RISK OF DEVELOPING METASTASIS FOLLOWING NEPHRECTOMY
Vijayshree Yadav STUDY00016600 A randomized, controlled trial of low-fat diet for fatigue in multiple sclerosis
Charles Lopez STUDY00016609 AM0010-301: A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compared with FOLFOX Alone as Second-line Therapy in Patients with Metastatic Pancreatic Cancer that has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Aaron Ziegler STUDY00016619 Epidemiology of Vocal Health in Dysphonic Patients Using Marijuana: A Multicenter Survey Study
Amira Al-Uzri STUDY00016623 Pharmacokinetics of Anti-epileptic Drugs in Obese Children
Stephen Spurgeon STUDY00016624 A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination with Acalabrutinib (ACP-196) in Subjects with Previously Untreated Mantle Cell Lymphoma
Emma Scott STUDY00016649 Phase 2, Randomized, Open-Label Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients With Newly Diagnosed Multiple Myeloma Eligible for High-Dose Chemotherapy and Autologous Stem Cell Transplantation
Matthew Taylor STUDY00016676 A Phase 1 study of the highly-selective RET inhibitor, BLU-667, in patients with thyroid cancer, non-small cell lung cancer (NSCLC) and other advanced solid tumors
Rodney Pommier STUDY00016689 An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastrointestinal (GI), or thoracic origin or poorly-differentiated gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC), that have progressed on prior treatment
Prakash Ambady STUDY00016709 The use of perfusion MRI using ferumoxytol and small molecular weight gadolinium (Gd) agents to assess response to pembrolizumab in brain metastases and systemic lesions in NSCLC: A comparison of imaging modalities to address brain metastases, pseudoprogression and systemic lesion tumor flare (neuro-check pilot)
Koenraad De Geest STUDY00016716 (TESARO 4010-01-001) A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors
Matthew Taylor STUDY00016732 A Phase 1/2a Study of BMS-986178 Administered Alone and in Combination with Nivolumab or Ipilimumab in Advanced Solid Tumors
Glenn Woodworth STUDY00016736 Ultrasound Assisted Thoracic Epidural Placement
Martha Goetsch STUDY00016770 Treating Where it Hurts: A randomized blinded clinical trial of local estrogen to the vulvar vestibule for dyspareunia in postmenopausal women
Myriam Loyo STUDY00016776 Exploratory Study of the Central Nervous System Response in Facial Synkinesis after Bell's palsy
Steven Shea STUDY00016803 Sleep and Circadian Mechanisms Contributing to Disparity in Prevalence of Hypertension Between Black and White Americans
Matthew Taylor STUDY00016804 A Multicenter Phase 1, Open-Label Study of DCC-3014 to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients with Advanced Malignancies
Sarah Nagle STUDY00016830 [NCI CIRB] A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Uma Borate STUDY00016834 A Phase 1b/2 Study of Entospletinib (GS-9973) Monotherapy and in Combination with Chemotherapy in Patients with Acute Myeloid Leukemia (AML)
Matthew Taylor STUDY00016851 M16-300: A Phase 1/2 Study on the Safety of Rovalpituzumab Tesirine Administered in Combination with Nivolumab or Nivolumab and Ipilimumab for Adults with Extensive-Stage Small Cell Lung Cancer
David Lee STUDY00016865 The MIO project: Maintaining Independence in Older Adults Project
Uma Borate STUDY00016867 A Phase 1B Dose Escalation Study Evaluating the Safety and Pharmacokinetics of Venetoclax in Combination with Azacitidine in Subjects with Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
Amy Holley STUDY00016872 Light Sensitivity in Pediatric Musculoskeletal Pain
Matthew Taylor STUDY00016883 CA209-915: A Phase 3, Randomized Study of Adjuvant Immunotherapy with Nivolumab Combined with Ipilimumab Versus Nivolumab Monotherapy after Complete Resection of Stage IIIb/c/d or Stage IV Melanoma
Matthew Taylor STUDY00016884 INCB 24360-207 Protocol Title: A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Jeremy Cetnar STUDY00016887 A Randomized, Open-Label, Multicenter, Phase 3 Study of Rovalpituzumab Tesirine Compared with Topotecan for Subjects with Advanced or Metastatic DLL3high Small Cell Lung Cancer (SCLC) who have First Disease Progression During or Following Front-Line Platinum-Based Chemotherapy
Eric Anderson STUDY00016890 A Phase III Study of BBI-608 plus nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma
Gina Vaccaro STUDY00016893 A Phase I/II Open Label Multi-Center Study of Immune Checkpoint Therapy with Nivolumab for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
Elie Traer STUDY00016896 A Multicenter Phase 1, Open-Label Study of DCC-3014 to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients with Advanced Malignancies
Myriam Loyo STUDY00016901 Pilot study of facial electrical stimulation to promote recovery in patients with facial paralysis from Bell’s palsy
Donald Thomas STUDY00016902 AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)
Jeffrey Jensen STUDY00016913 A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain
Dennis Crawford STUDY00016924 A Randomized Controlled Trial of the Subchondroplasty® Procedure with Arthroscopy versus Arthroscopy Alone for Treatment of Bone Marrow Lesions in the Knee
Thomas Hwang STUDY00016932 Wide-field and Projection-Resolved Optical Coherence Tomography Angiography in Diabetic Retinopathy
Michael Heinrich STUDY00016941 Determining Change in Cardiovascular and Metabolic Risks in Patients with Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Kim-Hien Dao STUDY00016964 A Phase 1/1b, Multicenter, Open-label, Dose-Escalation Study of FT-2102 as a Single Agent and in Combination with Azacitidine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome with an IDH1 Mutation
Richard Maziarz STUDY00016982 A Phase I Study of Donor BPX-501 T Cell Infusion for Adults with Recurrent or Minimal Residual Disease Hematologic Malignancies Post-Allogeneic Transplant
Koenraad De Geest STUDY00016998 (APR-407) PiSARRO: p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin/Pegylated Liposomal Doxorubicin (PLD) Combination Chemotherapy With or Without APR-246
Alexey Danilov STUDY00017005 IIT Phase I Study of pevonedistat (MLN4924, TAK924) in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and non-Hodgkin lymphoma
Sabra Leitenberger STUDY00017007 Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients from 6 to Less than 18 Years of Age with Moderate-to-Severe Plaque Psoriasis
James Mudd STUDY00017014 Effects of dapagliflozin on Biomarkers, Symptoms and Functional Status in Patients with Type 2 Diabetes or Pre-Diabetes, and Preserved Ejection Fraction Heart Failure (PRESERVED-HF Trial)
Edward Neuwelt STUDY00017028 The feasibility of Steady state CBV mapping using ferumoxytol immediately after Gadolinium enhanced MRI of the CNS
William Gregory STUDY00017056 The Impact of Local Estrogen on the Urogenital Microbiome in Genitourinary Syndrome of Menopause
Nima Nabavizadeh STUDY00017075 [NCI CIRB] RTOG 0848: A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (PH II-R)and Chemoradiation (PH III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Afshan Nanji STUDY00017083 Zoster Eye Disease Study (ZEDS): A multi-center, randomized, double-masked, placebo-controlled study of valacyclovir in immunocompetent subjects with a history of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) within the year prior to enrollment.
Charles Lopez STUDY00017094 A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)
John Vetto STUDY00017104 DecisionDx-Melanoma 31-Gene Expression Profile Clinical Impact Study
Zahi Mitri STUDY00017111 [18F] Fluoroestradiol (FES) PET as a Predictive Measure for Endocrine Therapy in Patients with Newly Diagnosed Metastatic Breast Cancer
Frederick Gallun STUDY00017116 Brain Training For Central Auditory Dysfunction After Traumatic Brain Injury
Gary Takahashi STUDY00017126 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton’s Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab versus Placebo in Combination with Rituximab in Treatment Naïve Subjects with Follicular Lymphoma
Gabrielle Meyers STUDY00017140 GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Charles Thomas STUDY00017143 Pilot Study for the Identification of Candidate Urinary Biomarkers for Hepatocellular Carcinoma
Steven Shea STUDY00017149 Cannabis Use Habits and Sleep an Online Survey
Michael Heinrich STUDY00017155 A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, Efficacy and Pharmacokinetics in Patients with Advanced Malignancies
Matthew Brodsky STUDY00017161 A Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase II Study to Evaluate the Efficacy of Intravenous RO7046015 (PRX002) in Participants with Early Parkinson's Disease With a 52-Week Blinded Extension (PASADENA)
Lara Davis STUDY00017190 A phase 1B trial of preoperative eribulin and radiation for retroperitoneal liposarcoma
Emma Scott STUDY00017199 A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared with CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis
Laurie King STUDY00017206 Reactive Responses and Locomotor Adjustments after Concussion
Lucinda Hugos STUDY00017223 VAPORHCS/OHSU J: Evaluation of a Spasticity Management Program for People with Multiple Sclerosis
Firas Zahr STUDY00017224 Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advanced Heart Failure: A Randomized Trial (TAVR UNLOAD)
Jeffrey Jensen STUDY00017248 What are OHSU employees’ opinions of clinical research and their participation as research subjects and what are the predominant barriers that employees face in considering participation?
Eric Suhler STUDY00017285 A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non infectious Uveitis
Jeffrey Jensen STUDY00017289 An open-label, parallel-group, randomized, multicenter study to assess the safety and efficacy of Vilaprisan in subjects with uterine fibroids versus standard of care
Steven Shea STUDY00017294 Chronotherapeutic use of Vitamin C to reduce morning cardiovascular risk
William Hoffman STUDY00017321 VAPORHCS/OHSU J:Neurobiology of Alcohol and Nicotine Co-Addiction
Laurie King STUDY00017370 VAPORHCS/OHSU J:Rehabilitation of Complex TBI with Sensory Integration Balance Deficits; Can Early Initiation of Rehabilitation with Wearable Sensor Technology Improve Outcomes?
Uma Borate STUDY00017379 Phase 1b, multi-arm, open-label study of PDR001 and/or MBG453 in combination with decitabine in patients with acute myeloid leukemia or high risk myelodysplastic syndrome
Christopher Ryan STUDY00017381 [NCI CIRB] A PHASE III RANDOMIZED TRIAL TO EVALUATE THE INFLUENCE OF BCG STRAIN DIFFERENCES AND T CELL PRIMING WITH INTRADERMAL BCG BEFORE INTRAVESICAL THERAPY FOR BCG-NAÏVE HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER
Michael Heinrich STUDY00017418 A Phase 3, Multi-Center, Open-Label Randomized Study of Oral ABL001 Versus Bosutinib in Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or more Tyrosine Kinase Inhibitors
Zahi Mitri STUDY00017461 [NCI CIRB] A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with ≥ 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
Kathryn Chung STUDY00017490 VAPORHCS/OHSU J: Clinical Characteristics of Parkinson’s Disease Subjects with Severe Hypertension During Motor Offs.
Seunggu Han STUDY00017499 An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults with Recurrent or Progressive Glioblastoma
Jacqueline Vuky STUDY00017504 MonarchE: Protocol 13Y-MC-JPCF A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Nicole Fett STUDY00017508 C0251002: A Phase 2A, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of PF 06823859 in Adult Subjects with Dermatomyositis
Paul Duell STUDY00017553 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Alirocumab in Patients with Homozygous Familial Hypercholesterolemia (R727-CL-1628)
Eric Anderson STUDY00017574 A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (B-FAST: Blood-First Assay Screening Trial
Laurie King STUDY00017619 ZeroG TRIP: Training Responses in Postural Rehabilitation
Jeffrey Jensen STUDY00017628 A Phase 3b Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women
Rajan Kulkarni STUDY00017648 VAPORHCS/OHSU J: Isolation and analysis of circulating tumor cells (CTCs) and nucleic acids from patient blood specimens
Jeffrey Jensen STUDY00017651 Effect of the addition of an oral androgen (dehydroepiandrosterone) on hepatic globulins in users of an antiandrogenic combined oral contraceptive (ethinyl estradiol/ drospirenone)
John Nutt STUDY00017656 Incidence of Parkinson's disease (PD) in Welches, Oregon
Michael Heinrich STUDY00017673 A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of DCC-2618 In Patients with AdvanCed Gastrointestinal Stromal TUmorS who have Received Treatment with Prior Anticancer Therapies
Matthew Taylor STUDY00017674 A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers
Khaled Tolba STUDY00017685 CA209-816 - Randomized, Open-Label, Phase 3 Trial of Nivolumab plus Ipilimumab or Nivolumab plus Platinum-Doublet Chemotherapy versus Platinum-Doublet Chemotherapy in Early Stage NSCLC
Amira Al-Uzri STUDY00017712 A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome
Tomasz Beer STUDY00017717 A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Samuel Camacho STUDY00017719 A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 over 12 Weeks in Patients with Heart Failure with Preserved Ejection Fraction
Firas Zahr STUDY00017739 Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR (COAPT) Continued Access Study
Roger Dailey STUDY00017768 A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects with Active Thyroid Eye Disease
Martina Mancini STUDY00017805 Improving Walking Automaticity in Parkinson’s Disease: Levodopa or Donepezil?
Craig Okada STUDY00017820 A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621, a Novel Biologic Targeting CD47, in Subjects with Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors
Zahi Mitri STUDY00017887 A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of SGN-LIV1A in Patients With Metastatic Breast Cancer
Richie Kohli STUDY00017903 Oral Health Clinical Training and Dental Referral Program for Nurses in Oregon: An Interprofessional Collaborative Project
James Mudd STUDY00017910 Randomized, Double-blind, Crossover, Placebo-controlled, Adaptive Design Study of Safety, Tolerability, Preliminary Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of MYK-491 in Patients with Stable Heart Failure
Joseph Bubalo STUDY00017916 Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles
Penelope Hogarth STUDY00017995 [SMART IRB] Fox BioNet LRRK2-002: Detection of LRRK2 activity in human biospecimens
Casey Seideman STUDY00017999 Disorders of Sexual Development Translational Research Network
Joyanna Hansen STUDY00018026 Eating competence and its relationship to dietary behaviors in pregnant women
Jeffrey Jensen STUDY00018041 CCN012B: A multicenter, open-label randomized study on the efficacy, cycle control and safety of a contraceptive vaginal ring delivering a daily dose of Nestorone® and estradiol (NES-E2 CVR)
Steven Shea STUDY00018052 Effect of tetrahydrocannabinol (THC) on sleep in humans
Christopher Ryan STUDY00018084 S1609, "DART: DUAL ANTI-CTLA-4 AND ANTI-PD-1 BLOCKADE IN RARE TUMORS”
Jessica Castle STUDY00018241 Assessment of a novel sensing catheter during automated insulin delivery in patients with Type 1 Diabetes
Nora Doty STUDY00018244 Effect of initiation of intrauterine contraception on hair cortisol concentration
Michael Shapiro STUDY00018271 A Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Phase 2 Study of ISIS 678354 Administered Subcutaneously to Patients with Hypertriglyceridemia and Established Cardiovascular Disease (CVD)
 

You may also qualify for Phase 1 Program trials.

 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080